Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.2K Sell
12,568
-7,884
-39% -$52.5K ﹤0.01% 10919
2026
Q1
$152K Sell
20,452
-74,319
-78% -$722K ﹤0.01% 10376
2025
Q4
$1.06M Buy
+94,771
New +$1.34M ﹤0.01% 5999
2024
Q4
– Sell
-3,450
Closed -$63.5K – 10203
2024
Q3
$63.5K Buy
3,450
+1,755
+104% +$29.2K ﹤0.01% 9125
2024
Q2
$32.1K Buy
+1,695
New +$37.9K ﹤0.01% 8994
2024
Q1
– Sell
-3,139
Closed -$60.9K – 9812
2023
Q4
$60.9K Buy
+3,139
New +$58.8K ﹤0.01% 8739
2023
Q3
– Sell
-1,693
Closed -$44.4K – 9146
2023
Q2
$44.4K Buy
+1,693
New +$47.2K ﹤0.01% 8234

Other funds holding NVX

Jane Street's NVX Position: Q2 2026 in Review

Jane Street reduced its NOVONIX (NVX) stake by 39% in Q2 2026, selling an estimated $52.5K and leaving 12,568 shares worth $52.2K. The position accounts for ﹤0.01% of the portfolio, ranked #10919.

Jane Street first reported a position in NVX in Q2 2023 and has held it in 7 quarters since. The position peaked at $1.06M in Q4 2025. 25 funds tracked by Wall St. Rank hold NVX as of Q2 2026.

  • Jane Street held 12,568 shares of NOVONIX worth $52.2K as of Q2 2026.
  • Jane Street sold 7,884 NOVONIX shares in Q2 2026, an estimated $52.5K.
  • NOVONIX made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10919 holding.
  • Jane Street first reported a position in NOVONIX in Q2 2023 and has held it in 7 quarters since.
  • Jane Street's NOVONIX position peaked at $1.06M in Q4 2025.
  • 25 funds tracked by Wall St. Rank held NOVONIX as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.